Your browser doesn't support javascript.
loading
Live two-way video versus face-to-face treatment for depression, anxiety, and obsessive-compulsive disorder: A 24-week randomized controlled trial.
Kishimoto, Taishiro; Kinoshita, Shotaro; Kitazawa, Momoko; Hishimoto, Akitoyo; Asami, Takeshi; Suda, Akira; Bun, Shogyoku; Kikuchi, Toshiaki; Sado, Mitsuhiro; Takamiya, Akihiro; Mimura, Masaru; Sato, Yasunori; Takemura, Ryo; Nagashima, Kengo; Nakamae, Takashi; Abe, Yoshinari; Kanazawa, Tetsufumi; Kawabata, Yasuo; Tomita, Hiroaki; Abe, Koichi; Hongo, Seiji; Kimura, Hiroshi; Sato, Aiko; Kida, Hisashi; Sakuma, Kei; Funayama, Michitaka; Sugiyama, Naoya; Hino, Kousuke; Amagai, Toru; Takamiya, Maki; Kodama, Hideyuki; Goto, Kenichi; Fujiwara, Shuichiro; Kaiya, Hisanobu; Nagao, Kiichiro.
Afiliação
  • Kishimoto T; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
  • Kinoshita S; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
  • Kitazawa M; Graduate School of Interdisciplinary Information Studies, The University of Tokyo, Tokyo, Japan.
  • Hishimoto A; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Asami T; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Suda A; Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan.
  • Bun S; Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan.
  • Kikuchi T; Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Sado M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Takamiya A; Sato Hospital, Yamagata, Japan.
  • Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Sato Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Takemura R; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
  • Nagashima K; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Nakamae T; Akasaka Clinic, Tokyo, Japan.
  • Abe Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Kanazawa T; Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
  • Kawabata Y; Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
  • Tomita H; Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
  • Abe K; Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Hongo S; Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kimura H; Department of Neuropsychiatry, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Sato A; Department of Neuropsychiatry, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Kida H; Department of Psychiatry, Tohoku University Hospital, Sendai, Japan.
  • Sakuma K; Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Funayama M; Department of Psychiatry, Tohoku University Hospital, Sendai, Japan.
  • Sugiyama N; Himorogi Psychiatric Institute, Tokyo, Japan.
  • Hino K; Department of Psychiatry, Gakuji-kai Kimura Hospital, Chiba, Japan.
  • Amagai T; Department of Psychiatry, School of Medicine, International University of Health and Welfare, Chiba, Japan.
  • Takamiya M; Department of Psychiatry, School of Medicine, International University of Health and Welfare, Chiba, Japan.
  • Kodama H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Goto K; Asaka Hospital, Fukushima, Japan.
  • Fujiwara S; Asaka Hospital, Fukushima, Japan.
  • Kaiya H; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Tochigi, Japan.
  • Nagao K; Numazu Chuo Hospital, Shizuoka, Japan.
Psychiatry Clin Neurosci ; 78(4): 220-228, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38102849
ABSTRACT

AIM:

Live two-way video, easily accessible from home via smartphones and other devices, is becoming a new way of providing psychiatric treatment. However, lack of evidence for real-world clinical setting effectiveness hampers its approval by medical insurance in some countries. Here, we conducted the first large-scale pragmatic, randomized controlled trial to determine the effectiveness of long-term treatment for multiple psychiatric disorders via two-way video using smartphones and other devices, which are currently the primary means of telecommunication.

METHODS:

This randomized controlled trial compared two-way video versus face-to-face treatment for depressive disorder, anxiety disorder, and obsessive-compulsive disorder in the subacute/maintenance phase during a 24-week period. Adult patients with the above-mentioned disorders were allocated to either a two-way video group (≥50% video sessions) or a face-to-face group (100% in-person sessions) and received standard treatment covered by public medical insurance. The primary outcome was the 36-Item Short-Form Health Survey Mental Component Summary (SF-36 MCS) score. Secondary outcomes included all-cause discontinuation, working alliance, adverse events, and the severity rating scales for each disorder.

RESULTS:

A total of 199 patients participated in this study. After 24 weeks of treatment, two-way video treatment was found to be noninferior to face-to-face treatment regarding SF-36 MCS score (48.50 vs 46.68, respectively; p < 0.001). There were no significant differences between the groups regarding most secondary end points, including all-cause discontinuation, treatment efficacy, and satisfaction.

CONCLUSION:

Two-way video treatment using smartphones and other devices, was noninferior to face-to-face treatment in real-world clinical settings. Modern telemedicine, easily accessible from home, can be used as a form of health care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão / Transtorno Obsessivo-Compulsivo Limite: Adult / Humans Idioma: En Ano de publicação: 2024

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão / Transtorno Obsessivo-Compulsivo Limite: Adult / Humans Idioma: En Ano de publicação: 2024